4//SEC Filing
Ainsworth Sean 4
Accession 0001140361-22-037954
CIK 0001228627other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:01 PM ET
Size
6.7 KB
Accession
0001140361-22-037954
Insider Transaction Report
Form 4
Ainsworth Sean
Director
Transactions
- Exercise of In-Money
Common Stock
2022-10-19$0.00/sh+1,574$0→ 41,239 total - Exercise of In-Money
Series B Warrant (right to buy)
2022-10-19−1,574→ 0 totalExercise: $0.00From: 2020-11-19Exp: 2022-10-20→ Common Stock (1,574 underlying)
Footnotes (1)
- [F1]The expiration date of the Series B Warrants occurred on the later of (x) the Reservation Date (as defined in the Series B Warrants) and (y) the date on which the Series B Warrants were exercised in full.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001830296
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 4:01 PM ET
- Size
- 6.7 KB